Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Next Bridge Hydrocarbons, Inc. reported 288,458,813 shares of common stock outstanding as of November 13, 2026. The filing indicates the company is classified as a non-accelerated filer, a smaller reporting company, and an emerging growth company, with financial statements covering the quarter ended September 30, 2026.
Annovis Bio reported third quarter 2026 financial results and provided a clinical update on its Phase 3 DUET-AD study for Alzheimer's disease, with a data readout expected in March 2027. The company also highlighted a $21.0 million capital raise from an underwritten public offering intended to fund operations through the upcoming clinical milestones.
Term
Q3 2026
“The third quarter marked a shift in our focus from enrolling patients in DUET-AD to executing the trial and preparing for the first data readout and for filing a New Drug Application (NDA). We now have dates set for last patient, last visit of the 6-month treatment period and for database lock, as well as financing in place to carry us through topline results in March 2027. The team is working very hard to deliver clean data and an on-time readout.”
Maria Maccecchini, PhD, President and CEO of Annovis
For the nine months ended September 30, 2026, Versus Systems reported total revenues of $1.51 million, primarily driven by related party transactions, and a net loss of $0.89 million. The company strengthened its balance sheet through the issuance of common stock, raising $1.7 million in financing during the period.
For the nine months ended September 30, 2026, Fidelity Private Credit Co LLC reported total investment income of $124.4 million and net expenses of $57.0 million. The company completed a merger on July 31, 2026, with Fidelity Private Credit Company II LLC, resulting in a net asset value per unit of $10.25 as of the end of the period.
For the three months ended September 30, 2026, Paramount Gold Nevada Corp. reported a net loss of $4.56 million, compared to a $4.32 million loss in the prior year period. The loss was primarily driven by non-cash items, including a $2.09 million loss from the change in fair value of derivative liabilities and a $346,706 loss from the change in fair value of warrant liabilities.
Koil Energy Solutions reported a significant revenue increase to $10.3 million for the quarter ended September 30, 2026, compared to $6.4 million in the prior year. The company achieved a net income of $0.2 million for the quarter, a turnaround from a net loss of $0.4 million in the same period of 2025.
Stonepeak-Plus Infrastructure Fund LP is an emerging growth company that conducts its investment activities primarily through the Master Aggregator. As of October 16, 2026, the registrant reported a complex capital structure with over 34 million units outstanding across various classes, including Class Z and Class X units.
The 21Shares Ethereum Staking ETF reported net assets of $37.55 million as of September 30, 2026, with 50.90% of its ether holdings currently staked. While the Trust generated $212,356 in staking rewards for the first nine months of 2026, it recorded a net decrease in net assets from operations of $3.23 million due to realized losses on ether sold for cash redemptions.
Monroe Federal Bancorp reported a net loss of $69,202 for the six months ended September 30, 2026, compared to a net loss of $228,615 in the prior year period. Total assets increased slightly to $144.2 million, while stockholders' equity decreased to $11.5 million primarily due to $868,262 in other comprehensive losses from unrealized losses on available-for-sale securities.
FGI Industries Ltd. reported a decrease in revenue to $94.1 million for the nine months ended September 30, 2026, compared to $100.1 million in the prior year period. The company experienced a net loss for the period, with total shareholders' equity declining to $14.2 million from $15.6 million at year-end 2025.
GlobalTech Corp reported a restatement of its December 31, 2025, financial statements due to an error in accounting for the realizability of deferred tax assets. The company's balance sheet as of September 30, 2026, shows cash and cash equivalents of $607,635 and a significant decrease in accounts receivable and inventory compared to the restated 2025 year-end figures.
Genprex, Inc. reported a net loss of $13.1 million for the nine months ended September 30, 2026, compared to $12.4 million in the prior year period. The company significantly strengthened its cash position to $15.3 million through $18.7 million in net proceeds from common stock issuances, supporting its ongoing clinical development of gene therapies for oncology and diabetes.
Urban One reported a net loss of $119.2 million for the quarter ended September 30, 2026, primarily driven by a $128.9 million impairment charge. Net revenue decreased to $88.0 million from $92.7 million in the prior year period, while the company completed the acquisition of Service Broadcasting Group during the quarter.
Adient plc identifies significant risks related to the adoption of AI, evolving automotive trends like autonomous vehicles, and increasing sustainability reporting requirements. The company also highlights potential financial impacts from warranty claims, product recalls, and global tax audits.
Natural Alternatives International reported a significant decline in net sales to $28.1 million for the quarter ended September 30, 2026, compared to $37.7 million in the prior year. The company experienced a net loss of $2.5 million and noted a 'going concern' risk due to non-compliance with credit agreement covenants and the acceleration of its mortgage note payable.
Oncolytics Biotech Inc. reported a net loss of $28.4 million for the nine months ended September 30, 2026, compared to $19.9 million in the prior year period, driven by increased R&D and G&A expenses. The company's cash position decreased to $2.4 million, leading management to issue a going concern warning as existing resources are insufficient to fund operations for the next twelve months.
Gaxos.ai reported Q3 2026 financial results featuring record consolidated revenue of $2.81 million, a 464.9% increase year-over-year. The company highlighted improved operational efficiency, with revenue per dollar of advertising expense increasing 38% sequentially to $1.08. As of September 30, 2026, the company maintained a cash position of approximately $13.30 million.
Term
Q3 2026
“Our third quarter results show continued revenue growth alongside lower advertising and marketing expense. We achieved record consolidated revenue while improving revenue per dollar of advertising and marketing expense by approximately 38% from the second quarter. We remain focused on improving customer acquisition efficiency and scaling products and channels with favorable contribution economics.”
Vadim Mats, CEO of Gaxos
“We are continuously fine-tuning our approach to customer acquisition. Our revenue generated per advertising dollar showed significant improvement as we work on strategy As always, we strive to continue building on our progress.”
FiEE, Inc. reported its third quarter 2026 financial results, highlighted by a significant revenue surge of 382.1% to $9.6 million for the first nine months of the year. The company achieved a profit turnaround with net income of $3.6 million for the nine-month period, driven by a strategic shift from legacy hardware to AI-integrated SaaS and digital art advisory services.
Term
Q3 2026
“We delivered solid financial results during the period and made meaningful progress in building a more diversified, scalable digital services platform.”
Rafael Li, Chief Executive Officer and President of FiEE
CO2 Energy Transition Corp. reported net income of $680,745 for the nine months ended September 30, 2026, primarily driven by $1.58 million in interest earned on trust account investments. During the period, the company experienced significant redemptions, with common stock subject to possible redemption decreasing from 6,900,000 shares to 1,030,715 shares.
Churchill Capital Corp XII is a shell company that completed its IPO on April 29, 2026, raising $414 million held in a Trust Account for a future business combination. As of September 30, 2026, the company has 41,750,000 Class A and 13,800,000 Class B ordinary shares outstanding and is classified as an emerging growth company.
Churchill Capital Corp XIII is a shell company that completed its initial public offering on August 3, 2026, raising $414,000,000 held in a U.S.-based trust account. As of September 30, 2026, the company is in its search phase for an initial business combination and has until at least August 3, 2028, to consummate a transaction.
Forge Nano reported total net sales of $6.07 million for the nine months ended September 30, 2026, a 14% increase year-over-year, though it faced a significant gross loss of $5.04 million. The company's net loss widened to $44.5 million for the period, driven by increased operating expenses and an $11.2 million nonoperating expense related to debt and warrant fair value changes.
Enveric Biosciences reported a net loss of $7.21 million for the nine months ended September 30, 2026, compared to $6.58 million in the prior year period, driven by increased research and development costs. The company strengthened its cash position to $5.61 million through various financing activities, including private placements and warrant exercises, resulting in a total shareholders' equity of $5.73 million.
Empire Petroleum reported a net loss of $12.0 million for the nine months ended September 30, 2026, compared to a $13.1 million loss in the prior year period. While total product revenues increased to $29.2 million, the company's bottom line was impacted by a $5.0 million loss on derivatives and significant operating expenses.
Auddia Inc. reported a net loss of $7.37 million for the nine months ended September 30, 2026, compared to a $5.70 million loss in the prior year period. While the company began generating modest revenue of $22,268, operating expenses increased significantly due to higher sales, marketing, and transaction costs related to a proposed merger with Thramann Holdings.
WhiteHawk Minerals Corp. reported a net loss of $33.4 million for the nine months ended September 30, 2026, primarily driven by a $21.7 million loss on debt extinguishment and increased management fees. Despite the year-to-date loss, the company achieved a net income of $6.9 million in the third quarter of 2026, supported by $17.0 million in royalty revenue and a $3.2 million gain on commodity derivatives.
URSB Bancorp, Inc. reported net income of $653 thousand for the nine months ended September 30, 2026, compared to $327 thousand in the prior year period. The company completed its initial public offering during the first quarter of 2026, significantly increasing total shareholders' equity to $39.3 million.
Aptera Motors Corp. reported a net loss of $35.0 million for the nine months ended September 30, 2026, compared to a $28.4 million loss in the prior year period, driven by increased research and development costs. The company remains in the development stage with zero revenue and a total accumulated deficit of $353.7 million as of the reporting date.
DataMEDS AI reported Q3 2026 revenue of $2.7 million, representing 50% sequential growth driven by its Corexa Pharmacy drug dispensing business. The company achieved a net profit of $2.72 per share and regained full compliance with Nasdaq listing standards during the period. Key strategic developments included the launch of the Health Lives Here mobile app and the acquisition of the Helomics cancer diagnostics laboratory.
Term
Q3 2026
“Corexa Pharmacy drove a 50% sequential increase in revenue this quarter with continued growth expected for the fourth quarter based upon the steps we have taken to add additional revenue streams of medical foods and diagnostic lab tests related to patients to whom we dispense prescriptions.”
Velos Acquisition I Corp. reported a net income of $2.90 million for the nine months ended September 30, 2026, primarily driven by $7.31 million in interest earned on Trust Account investments. During the period, the company experienced significant redemptions of Class A ordinary shares totaling $135.52 million and converted all Class B ordinary shares into Class A ordinary shares.